CMFRI to commercialise two seaweed-based nutraceuticals The Fishsite dated 20th December 2023

CMFRI, Library (2023) CMFRI to commercialise two seaweed-based nutraceuticals The Fishsite dated 20th December 2023. The Fishsite.

Text The Fishsite_20-12-2023.pdf Download (338kB)

Abstract

The Central Marine Fisheries Research Institute (CMFRI) has commercialised the patent-protected technologies of two seaweed-based nutraceutical products -one to boost anti-viral immunity and the other to combat high cholesterol or dyslipidemia. The products are expected to reach the market within six months from Pioneer Pharmaceuticals. Dr A. Gopalakrishnan, Director of the institute, had signed a licence agreement with Joby George, Managing Partner, Pioneer Pharmaceuticals Limited, a wellness and pharmaceutical company based in Kochi, for commercial production and marketing of the products.

Item Type:	Article
Subjects:	CMFRI News Clippings
Divisions:	Library and Documentation Centre
Depositing User:	Mr. Augustine Sipson N A
Date Deposited:	26 Dec 2023 08:56
Last Modified:	26 Dec 2023 08:56
URI:	http://eprints.cmfri.org.in/id/eprint/17838

Actions (login required)

View Item